MORGAN STANLEY - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 49 filers reported holding TRANSLATE BIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$19,225,000
+239.4%
698,131
+103.2%
0.00%
+200.0%
Q1 2021$5,665,000
+80.7%
343,529
+101.9%
0.00%
Q4 2020$3,135,000
+70.2%
170,153
+25.7%
0.00%
Q3 2020$1,842,000
+132.3%
135,350
+205.8%
0.00%
Q2 2020$793,000
+169.7%
44,266
+50.3%
0.00%
Q1 2020$294,000
-45.4%
29,456
-55.4%
0.00%
Q4 2019$538,000
+427.5%
66,089
+545.0%
0.00%
Q3 2019$102,000
+1940.0%
10,247
+2430.1%
0.00%
Q2 2019$5,000
-89.6%
405
-91.4%
0.00%
Q1 2019$48,000
-58.3%
4,708
-69.4%
0.00%
Q4 2018$115,000
-26.3%
15,378
-1.2%
0.00%
Q3 2018$156,00015,5570.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2018
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders